Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04148664 · ClinicalTrials.gov registry record · NA
A Trial of High Power-Short Duration Versus Standard Power-Long Duration Radiofrequency Ablation for Treatment of Atrial Fibrillation
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04148664 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants.
The verdict
NCT04148664, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study is a prospective, randomized controlled study to compare overall clinical outcomes between High Power Short Duration (HPSD) and standard radiofrequency (RF) ablation settings for Atrial Fibrillation (AF) ablation in the treatment of subjects with paroxysmal or persistent Atrial Fibrillation.
Interventions
- PROCEDURE Catheter ablation with Standard RF ablation settings
- PROCEDURE Catheter ablation with High Power Short Duration RF ablation settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-12-03 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04148664
The ClinicalTrials.gov registry entry for NCT04148664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Catheter ablation with Standard RF ablation settings is the first listed.
NCT04148664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04148664 about?
NCT04148664 is a clinical study titled "A Trial of High Power-Short Duration Versus Standard Power-Long Duration Radiofrequency Ablation for Treatment of Atrial Fibrillation". This study is a prospective, randomized controlled study to compare overall clinical outcomes between High Power Short Duration (HPSD) and standard radiofrequency (RF) ablation settings for Atrial Fibrillation (AF) ablation in the treatment of subjects with paroxysmal or persistent Atrial Fibrillati...
What is the current status of trial NCT04148664?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-12-03. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT04148664?
The interventions under investigation include: Catheter ablation with Standard RF ablation settings (PROCEDURE), Catheter ablation with High Power Short Duration RF ablation settings (PROCEDURE).
Who is sponsoring clinical trial NCT04148664?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.